0001437749-21-008295.txt : 20210405 0001437749-21-008295.hdr.sgml : 20210405 20210405190854 ACCESSION NUMBER: 0001437749-21-008295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEDOUX MARK A CENTRAL INDEX KEY: 0001115556 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15701 FILM NUMBER: 21807407 MAIL ADDRESS: STREET 1: 1185 LINDA VISTA DR CITY: SAN MARCOS STATE: CA ZIP: 92069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC CENTRAL INDEX KEY: 0000787253 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 841007839 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1535 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008-7319 BUSINESS PHONE: 6197447340 MAIL ADDRESS: STREET 1: 1535 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008-7319 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC DATE OF NAME CHANGE: 19860929 4 1 rdgdoc.xml FORM 4 X0306 4 2021-03-31 0000787253 NATURAL ALTERNATIVES INTERNATIONAL INC NAII 0001115556 LEDOUX MARK A 1535 FARADAY AVENUE CARLSBAD CA 92008 1 1 1 CEO/Chairman Common Stock 2021-03-31 4 S 0 898 15.50 D 39193 D Common Stock 2021-03-31 4 S 0 1000 15.50 D 524000 I By LeDoux Family Limited Partnership Common Stock 2021-04-01 4 S 0 1602 15.50 D 37591 D Common Stock 2021-04-01 4 S 0 1500 15.50 D 522500 I By LeDoux Family Limited Partnership Common Stock 2021-04-05 4 S 0 2500 16.20 D 35091 D Common Stock 2021-04-05 4 S 0 2500 16.20 D 520000 I By LeDoux Family Limited Partnership Common Stock 176500 I By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992 Common Stock 69416 I By IRA Common Stock 7200 I By Self as Custodian for Marcelle Jeannette LeDoux Common Stock 800 I By Self as Custodian for Jean-Marc Emile LeDoux Common Stock 6000 I By Self as Custodian for Aimee LeDoux This transaction represents a sale pursuant to a Programmed Plan of Transactions Under Rule 10b5-1(c) of the Securities Exchange Act included as an Exhibit to Form 8-K filed with the SEC on March 26, 2021. /s/ By Kenneth E. Wolf Attorney in Fact 2021-04-05